Loading chart…
PRE-MARKET
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations.
Dr. Lal PathLabs Limited (LALPATHLAB) is listed on the NSE in the Healthcare sector, Diagnostics & Research industry. The LALPATHLAB share price is ₹1,970.00 (+0.16% today), with a market capitalisation of ₹329B and a price-to-earnings (P/E) ratio of 56.5. MarketRipple tracks the LALPATHLAB investment thesis, the ripple-chain impact of market events on Dr. Lal PathLabs Limited, and the Healthcare sector outlook.
Open
₹1,962.00
High
₹2,011.00
Low
₹1,935.00
Prev. Close
₹1,966.80
52W High
₹2,061.90
52W Low
₹1,272.60
Day range
₹1,935.00–₹2,011.00
52-week range
₹1,272.60–₹2,061.90
Volume
566K
P/E
56.5
ROE
22.6%
D/E
0.08
Margin
19.2%
Dr. Lal PathLabs Limited (NSE: LALPATHLAB) is currently trading at ₹1,970.00 (+0.16%).
Dr. Lal PathLabs Limited's market capitalization is ₹329B.
Dr. Lal PathLabs Limited's price-to-earnings (P/E) ratio is 56.5.
Dr. Lal PathLabs Limited operates in the Healthcare sector (Diagnostics & Research).
Analyst consensus on Dr. Lal PathLabs Limited currently reads positive, based on 26 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.